Amylin制药公司、Eli Lilly and Company公司和Alkermes公司宣布了一项临床研究的可喜阳性结果,此项研究用随机的方式让患者每周服用一次exenatide(Ⅰ)或服用Lantus(insulin glargine)(Ⅱ),并比较其疗效差异。AIC(糖化血红蛋...Amylin制药公司、Eli Lilly and Company公司和Alkermes公司宣布了一项临床研究的可喜阳性结果,此项研究用随机的方式让患者每周服用一次exenatide(Ⅰ)或服用Lantus(insulin glargine)(Ⅱ),并比较其疗效差异。AIC(糖化血红蛋白)在较长时间内(超过三个月)可以衡量平均血糖,在此项研究中将其作为平均血糖的衡量指标。经过26周的治疗,展开更多
Purpose: to evaluate the efficacy and safety of latanoprost eye drops treatment once daily vs. once a week. Methods: 10 patients with ocular hypertension without treatment or early glaucoma after washout of current tr...Purpose: to evaluate the efficacy and safety of latanoprost eye drops treatment once daily vs. once a week. Methods: 10 patients with ocular hypertension without treatment or early glaucoma after washout of current treatment participated in the study, one eye was randomly assigned to once a day drop and the other eye to once a week. IOP was measured before the initial展开更多
文摘Amylin制药公司、Eli Lilly and Company公司和Alkermes公司宣布了一项临床研究的可喜阳性结果,此项研究用随机的方式让患者每周服用一次exenatide(Ⅰ)或服用Lantus(insulin glargine)(Ⅱ),并比较其疗效差异。AIC(糖化血红蛋白)在较长时间内(超过三个月)可以衡量平均血糖,在此项研究中将其作为平均血糖的衡量指标。经过26周的治疗,
文摘Purpose: to evaluate the efficacy and safety of latanoprost eye drops treatment once daily vs. once a week. Methods: 10 patients with ocular hypertension without treatment or early glaucoma after washout of current treatment participated in the study, one eye was randomly assigned to once a day drop and the other eye to once a week. IOP was measured before the initial